Patent ID: 7282508

Claim:
A compound selected from the group consisting of 1-ethoxycarbonyl-4-phenyl-4-[1-(phenylmethyl)-1-H-imidazol-2-yl]-piperidine; 1-propyloxycarbonyl-4-phenyl-4-[1-(phenylmethyl)-1-H-imidazol-2-yl]-piperidine; 1-ethoxycarbonyl-4-phenyl-4-[1-[(4-hydroxyphenyl)methyl]-1-H-imidazol-2-yl]-piperidine; 1-ethoxycarbonyl-4-phenyl-4-[1-(1-phenylethyl)-1-H-imidazol-2-yl]-piperidine; 1-isopropyloxycarbonyl-4-phenyl-4-[1-(phenylmethyl)-1-H-imidazol-2-yl]-piperidine; 1-ethoxycarbonyl-4-phenyl-4-[1-[[4-(methoxycarbonyl)phenyl]methyl]- -1-H imidazol-2-yl]-piperidine; 1-benzoyl-4-phenyl-4-[1-(phenylmethyl)-1H-imidazol-2-yl]-piperidine; 1-(methoxyacetyl)-4-phenyl-4-[1-(1-phenylethyl)-1-H-imidazol-2-yl]-piperidine; 4-[[2-(1-benzoyl-4-phenyl-4-piperidinyl)-1-H-imidazol-1-yl]methyl]-methylbenzoate; 4-[[2-[1-(2-benzoxazolyl)-4-phenyl-4-piperidinyl]-1-H-imidazol-1-yl]methyl]-methylbenzoate; 1-benzoyl-4-phenyl-4-[1-(1-phenylethyl)-1-H-imidazol-2-yl]-piperidine; 1-ethoxycarbonyl-4-phenyl-4-[1-[1-[4-(ethoxycarbonyl)phenyl]ethyl]-1-H imidazol-2-yl]-piperidine; and N,4-diphenyl-4-[1-(phenylmethyl)-1-H-imidazol-2-yl]-1-Piperidinesulfonamide; or a pharmaceutically acceptable acid or base addition salt thereof, a stereochemically isomeric form thereof, a tautomeric form thereof, or an N-oxide form thereof.